T-cell lymphomas, a challenging disease: types, treatments, and future

T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against chemotherapy as well as intolerance in patients to the established and toxic chemotherapy regimens. In this review article, we discuss the epidem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Helen, Abdul-Hay, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102240/
https://www.ncbi.nlm.nih.gov/pubmed/27743148
http://dx.doi.org/10.1007/s10147-016-1045-2
_version_ 1783511783847231488
author Ma, Helen
Abdul-Hay, Maher
author_facet Ma, Helen
Abdul-Hay, Maher
author_sort Ma, Helen
collection PubMed
description T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against chemotherapy as well as intolerance in patients to the established and toxic chemotherapy regimens. In this review article, we discuss the epidemiology, pathophysiology, current standard of care, and future treatments of common types of T-cell lymphomas, including adult T-cell leukemia/lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large-cell lymphoma, aggressive NK/T-cell lymphoma, and cutaneous T-cell lymphoma.
format Online
Article
Text
id pubmed-7102240
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-71022402020-03-31 T-cell lymphomas, a challenging disease: types, treatments, and future Ma, Helen Abdul-Hay, Maher Int J Clin Oncol Review Article T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against chemotherapy as well as intolerance in patients to the established and toxic chemotherapy regimens. In this review article, we discuss the epidemiology, pathophysiology, current standard of care, and future treatments of common types of T-cell lymphomas, including adult T-cell leukemia/lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large-cell lymphoma, aggressive NK/T-cell lymphoma, and cutaneous T-cell lymphoma. Springer Japan 2016-10-14 2017 /pmc/articles/PMC7102240/ /pubmed/27743148 http://dx.doi.org/10.1007/s10147-016-1045-2 Text en © Japan Society of Clinical Oncology 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Ma, Helen
Abdul-Hay, Maher
T-cell lymphomas, a challenging disease: types, treatments, and future
title T-cell lymphomas, a challenging disease: types, treatments, and future
title_full T-cell lymphomas, a challenging disease: types, treatments, and future
title_fullStr T-cell lymphomas, a challenging disease: types, treatments, and future
title_full_unstemmed T-cell lymphomas, a challenging disease: types, treatments, and future
title_short T-cell lymphomas, a challenging disease: types, treatments, and future
title_sort t-cell lymphomas, a challenging disease: types, treatments, and future
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102240/
https://www.ncbi.nlm.nih.gov/pubmed/27743148
http://dx.doi.org/10.1007/s10147-016-1045-2
work_keys_str_mv AT mahelen tcelllymphomasachallengingdiseasetypestreatmentsandfuture
AT abdulhaymaher tcelllymphomasachallengingdiseasetypestreatmentsandfuture

Ejemplares similares